Renal biopsy is a potentially hazardous procedure, generally perfornedfor therapeutic reasons.
Introduction
Clinicians, researchers and editors have a moral duty to abide by the ethical codes which govern medical practice. The last half century has seen a shift in focus from physician-centred ethical thinking to a patient-centred approach. This places the interests of patients above those of doctors; researchers, authors and medical editors are not exempt from this responsibility-are readers? CASE REPORT In 1995 a journal published a communication reporting the histopathological findings in a patient with an inherited renal-concentrating defect. The The editorial office sent a copy of this to me; I found this explanation unsatisfactory and asked the editors whether they were proposing to publish the correspondence. In a letter dated 19 April 1996 a member of the editorial department wrote declining to publish, maintaining that the editorial decision was final.
COMMENT
This correspondence raises three important questions: medical, editorial and general. First, was the procedure unethical? The procedure satisfied no well established criteria for the performance of a renal biopsy. Although the authors say it was performed because they considered "that we should evaluate the prognosis of the disease" there is nothing in the literature to suggest that renal biopsy findings would help the management of the patient.
The authors suggest that the condition "often progresses to renal failure" but give no reference. There was no indication that this patient had either acute or chronic renal failure. The only clear-cut pre-biopsy abnormality was dilatation of the renal tract, a recognised complication of the primary condition (and which may cause renal insufficiency) but one whose management is not helped by knowledge 
